BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16150258)

  • 1. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs.
    Althuis MD; Scoccia B; Lamb EJ; Moghissi KS; Westhoff CL; Mabie JE; Brinton LA
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):668-74. PubMed ID: 16150258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine cancer after use of clomiphene citrate to induce ovulation.
    Althuis MD; Moghissi KS; Westhoff CL; Scoccia B; Lamb EJ; Lubin JH; Brinton LA
    Am J Epidemiol; 2005 Apr; 161(7):607-15. PubMed ID: 15781949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian cancer risk after the use of ovulation-stimulating drugs.
    Brinton LA; Lamb EJ; Moghissi KS; Scoccia B; Althuis MD; Mabie JE; Westhoff CL
    Obstet Gynecol; 2004 Jun; 103(6):1194-203. PubMed ID: 15172852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study.
    Hannibal CG; Jensen A; Sharif H; Kjaer SK
    Hum Reprod; 2008 Feb; 23(2):451-6. PubMed ID: 18065402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study.
    Jensen A; Sharif H; Kjaer SK
    Am J Epidemiol; 2009 Dec; 170(11):1408-14. PubMed ID: 19884127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer risk associated with ovulation-stimulating drugs.
    Brinton LA; Scoccia B; Moghissi KS; Westhoff CL; Althuis MD; Mabie JE; Lamb EJ
    Hum Reprod; 2004 Sep; 19(9):2005-13. PubMed ID: 15217997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant melanoma risk after exposure to fertility drugs: results from a large Danish cohort study.
    Hannibal CG; Jensen A; Sharif H; Kjaer SK
    Cancer Causes Control; 2008 Sep; 19(7):759-65. PubMed ID: 18340541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study.
    Jensen A; Sharif H; Svare EI; Frederiksen K; Kjaer SK
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1400-7. PubMed ID: 17585058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial risk of cancer shortly after diagnosis of the first familial tumor.
    Bermejo JL; Hemminki K
    J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of sterility and melanoma].
    Schmutz JL; Barbaud A; Trechot P
    Ann Dermatol Venereol; 2002 Oct; 129(10 Pt 1):1211. PubMed ID: 12442144
    [No Abstract]   [Full Text] [Related]  

  • 11. Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study.
    Orgéas CC; Sanner K; Hall P; Conner P; Holte J; Nilsson SJ; Sundfeldt K; Persson I; Chia KS; Wedren S; Dickman PW; Czene K
    Am J Obstet Gynecol; 2009 Jan; 200(1):72.e1-7. PubMed ID: 19121659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of second primary malignancies in women with papillary thyroid cancer.
    Canchola AJ; Horn-Ross PL; Purdie DM
    Am J Epidemiol; 2006 Mar; 163(6):521-7. PubMed ID: 16421240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fertility Drugs Associated with Thyroid Cancer Risk: A Systematic Review and Meta-Analysis.
    Yu Q; Lv X; Liu K; Ma D; Wu Y; Dai W; Jiang H
    Biomed Res Int; 2018; 2018():7191704. PubMed ID: 29862285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden.
    Sanner K; Conner P; Bergfeldt K; Dickman P; Sundfeldt K; Bergh T; Hagenfeldt K; Janson PO; Nilsson S; Persson I
    Fertil Steril; 2009 Apr; 91(4):1152-8. PubMed ID: 18371964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovulation induction treatment and risk of borderline ovarian tumors.
    Cusidó M; Fábregas R; Pere BS; Escayola C; Barri PN
    Gynecol Endocrinol; 2007 Jul; 23(7):373-6. PubMed ID: 17701767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood tumor risk after treatment with ovulation-stimulating drugs.
    Brinton LA; Krüger Kjaer S; Thomsen BL; Sharif HF; Graubard BI; Olsen JH; Bock JE
    Fertil Steril; 2004 Apr; 81(4):1083-91. PubMed ID: 15066468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence.
    Jacobs EJ; Thun MJ; Bain EB; Rodriguez C; Henley SJ; Calle EE
    J Natl Cancer Inst; 2007 Apr; 99(8):608-15. PubMed ID: 17440162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935-82.
    Tucker MA; Boice JD; Hoffman DA
    Natl Cancer Inst Monogr; 1985 Dec; 68():161-89. PubMed ID: 4088297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fertility drugs on cancers other than breast and gynecologic malignancies.
    Brinton LA; Moghissi KS; Scoccia B; Lamb EJ; Trabert B; Niwa S; Ruggieri D; Westhoff CL
    Fertil Steril; 2015 Oct; 104(4):980-988. PubMed ID: 26232746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.